InspireMD director buys 90,000 shares in open trade
InspireMD, Inc. director Gary S. Roubin made an open-market purchase of 90,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
InspireMD, Inc. director Gary S. Roubin made an open-market purchase of 90,000 shares of Common Stock. He bought the shares at a weighted average price of $1.18 per share, through multiple trades between $1.15 and $1.20. Following this transaction, he directly owns 834,478 shares, increasing his personal stake in the company.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 90,000 | $1.18 | $106K |
Footnotes (1)
- F1. The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Key Figures
Key Terms
open-market purchase financial
weighted average price financial
Securities and Exchange Commission regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did InspireMD (NSPR) director Gary S. Roubin report?
What does the price range disclosure mean in the InspireMD (NSPR) Form 4?
Is Gary S. Roubin’s InspireMD (NSPR) transaction a purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.